C
CARTESIAN THERAPEUTICS INC.
NASDAQ: RNAC (Cartesian Therapeutics, Inc.)
最近更新时间: 20小时之前6.49
-0.26 (-3.85%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Cartesian Therapeutics, Inc. | 混合的 | 混合的 |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | -4.0 |
| 相对估值 | NA |
| 财务健康 | -2.5 |
| 宏观环境 | -0.3 |
| AI Insight | NA |
| AI Technical | NA |
| 平均 | -0.27 |
|
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 59.96% |
| 机构持股比例 | 25.63% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Privium Fund Management B.V. | 30 Jun 2026 | 151,675 |
投资组合